Drugs / Benperidol
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT02374567 | Jan 2015 → Jun 2017 | anxiety disorder, dementia, depressive disorder, schizophrenia +1 | Hannover Medical School | Terminated | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02307396 | Feb 2015 → Jun 2016 | schizoaffective disorder, schizophrenia | Technical University of Munich | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01323205 Background | May 2011 → Nov 2012 | schizophrenia | Janssen Research & Development, LLC | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Benperidol | “Regular antipsychotic medications (Risperidone, Olanzapine, Clozapine, Amisulpride, Quetiapine, Paliperidone, Aripiprazole, Haloperidol, Levomepromazine, Zuclopenthixol...” NCT01323205 ↗ |
| Known as | Anquil | ChEMBL registry synonym — accepted as the source's own label CHEMBL297302 ↗ |
| Known as | Benquil | ChEMBL registry synonym — accepted as the source's own label CHEMBL297302 ↗ |
| Known as | MCN-JR-4584 | ChEMBL registry synonym — accepted as the source's own label CHEMBL297302 ↗ |
| Known as | NSC-170982 | ChEMBL registry synonym — accepted as the source's own label CHEMBL297302 ↗ |
| Known as | R-4584 | ChEMBL registry synonym — accepted as the source's own label CHEMBL297302 ↗ |
| Action | Inhibit | “Dopamine D2 receptor antagonist” CHEMBL297302 ↗ |
| Modality | Small molecule | — CHEMBL297302 ↗ |
| Target | DRD2 | “Dopamine D2 receptor antagonist” CHEMBL297302 ↗ |